Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for DOSEN UND VERFAHREN ZUR VERABREICHUNG VON TELAVANCIN
Details for 2016708853
Up to date per 16.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2016708853
Title / Product Name
DOSEN UND VERFAHREN ZUR VERABREICHUNG VON TELAVANCIN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2016708853
EP Publication Number
3261658
E-Number
1114906
Language
EN
PCT Number
US16018396
Publication Date
03.01.2018 A
03.04.2019 B1
Registration Date
03.04.2019
AT Publication Date
15.04.2019
Application Date
18.02.2016
Registration Number
-
Priorities
23.02.2015
US
201562119592 P
IPC
A61K 38/12 20060101AFI20170906BHEP
Maximum Duration of Protection
18.02.2036
Owner
Theravance Biopharma Antibiotics IP, LLC
901, Gateway Boulevard
South San Francisco, CA 94080
US
Representative
No representatives present
Inventor
BARRIERE, Steven L.
1660 Lyon Street
San Francisco, California 94115
US
LO, Arthur
1485 46th Avenue
San Francisco, California 94122
US
MAMMEN, Mathai
1852 Valparaiso Avenue
Menlo Park, California 94025
US
WORBOYS, Philip
30 Chester Way
San Mateo, California 94402
US